These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11328661

  • 21. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L.
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [Abstract] [Full Text] [Related]

  • 22. Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain.
    Sun H, Bungay PM, Elmquist WF.
    J Pharmacol Exp Ther; 2001 Jun; 297(3):991-1000. PubMed ID: 11356921
    [Abstract] [Full Text] [Related]

  • 23. [Blood-Brain Barrier (BBB)].
    Nakagawa S, Niwa M.
    Nihon Yakurigaku Zasshi; 2009 Mar; 133(3):170-2. PubMed ID: 19317007
    [No Abstract] [Full Text] [Related]

  • 24. [Blood plasma proteins and drug transport across the hemato-encephalic barrier].
    Lutsevich AN, Bender KI, Kupchikov VV.
    Farmakol Toksikol; 1991 Mar; 54(1):70-6. PubMed ID: 1860509
    [Abstract] [Full Text] [Related]

  • 25. Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer's disease.
    Deguchi Y, Hayashi H, Fujii S, Naito T, Yokoyama Y, Yamada S, Kimura R.
    J Drug Target; 2000 Mar; 8(6):371-81. PubMed ID: 11328663
    [Abstract] [Full Text] [Related]

  • 26. Blood-brain barrier transport of L-tyrosine Conjugates: a model study for the brain targeting using large neutral amino acid transport system.
    Ohnishi T, Maruyama T, Higashi S, Awazu S.
    J Drug Target; 2000 Mar; 8(6):395-401. PubMed ID: 11328665
    [Abstract] [Full Text] [Related]

  • 27. Investigation of the mechanism of enhancement of central nervous system delivery of 2'-beta-fluoro-2',3'-dideoxyinosine via a blood-brain barrier adenosine deaminase-activated prodrug.
    Johnson MD, Chen J, Anderson BD.
    Drug Metab Dispos; 2002 Feb; 30(2):191-8. PubMed ID: 11792690
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A, Begley DJ, Abbott NJ.
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
    [Abstract] [Full Text] [Related]

  • 31. Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier.
    Ito S, Ohtsuki S, Terasaki T.
    Neurosci Res; 2006 Nov; 56(3):246-52. PubMed ID: 16926058
    [Abstract] [Full Text] [Related]

  • 32. Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets.
    Puris E, Gynther M, de Lange ECM, Auriola S, Hammarlund-Udenaes M, Huttunen KM, Loryan I.
    Mol Pharm; 2019 Jul 01; 16(7):3261-3274. PubMed ID: 31180686
    [Abstract] [Full Text] [Related]

  • 33. Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
    Patching SG.
    Mol Neurobiol; 2017 Mar 01; 54(2):1046-1077. PubMed ID: 26801191
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ligand-Appended BBB-Targeted Nanocarriers (LABTNs).
    Jain A, Jain SK.
    Crit Rev Ther Drug Carrier Syst; 2015 Mar 01; 32(2):149-80. PubMed ID: 25955883
    [Abstract] [Full Text] [Related]

  • 38. Prodrug based optimal drug delivery via membrane transporter/receptor.
    Yang C, Tirucherai GS, Mitra AK.
    Expert Opin Biol Ther; 2001 Mar 01; 1(2):159-75. PubMed ID: 11727527
    [Abstract] [Full Text] [Related]

  • 39. Strategies for increasing drug delivery to the brain: focus on brain lymphoma.
    Siegal T, Zylber-Katz E.
    Clin Pharmacokinet; 2002 Mar 01; 41(3):171-86. PubMed ID: 11929318
    [Abstract] [Full Text] [Related]

  • 40. Drug delivery across the blood-brain barrier.
    Chen Y, Dalwadi G, Benson HA.
    Curr Drug Deliv; 2004 Oct 01; 1(4):361-76. PubMed ID: 16305398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.